PROX1, prospero homeobox 1, 5629

N. diseases: 114; N. variants: 10
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0024232
Disease: Lymphatic Metastasis
Lymphatic Metastasis
0.010 AlteredExpression disease BEFREE Subsequently, exosomal LNMAT2 was internalized by HLECs and epigenetically upregulated prospero homeobox 1 (PROX1) expression by recruitment of hnRNPA2B1 and increasing the H3K4 trimethylation level in the PROX1 promoter, ultimately resulting in lymphangiogenesis and lymphatic metastasis. 31593555 2020
CUI: C0015967
Disease: Fever
Fever
0.010 AlteredExpression phenotype BEFREE However, centrally we did observe age-specific interaction effects of HT and ELS with regard to hippocampal glucocorticoid receptor mRNA expression, neurogenesis with the immature neurone marker doublecortin and the number of hilar (ectopic) granule cells using Prox1 staining. 30773738 2019
CUI: C2931367
Disease: Thyroid cancer, follicular
Thyroid cancer, follicular
0.010 Biomarker disease BEFREE Herein, we studied the role of PROX1 in angiogenesis in cell lines derived from follicular thyroid cancer (FTC: FTC-133) and squamous cell carcinoma of the thyroid gland (SCT: CGTH-W-1) upon <i>PROX1</i> knockdown. 31717665 2019
CUI: C0010346
Disease: Crohn Disease
Crohn Disease
0.010 AlteredExpression disease BEFREE The aim of the study was to assess the correlation between the expression of Prox1 and postoperative recurrence in Crohn's disease [CD]. 29947772 2018
CUI: C0010606
Disease: Adenoid Cystic Carcinoma
Adenoid Cystic Carcinoma
0.010 AlteredExpression disease BEFREE High Expression of Prospero-Related Homeobox-1 (PROX1) Is Associated With Poor Prognosis in Patients With Salivary Adenoid Cystic Carcinoma. 29406257 2018
CUI: C0011303
Disease: Demyelinating Diseases
Demyelinating Diseases
0.010 Biomarker group BEFREE Therefore, Prox1 could be a potential modulator of demyelinating diseases in clinical settings. 29931031 2018
CUI: C0018553
Disease: Hamartoma Syndrome, Multiple
Hamartoma Syndrome, Multiple
0.010 AlteredExpression disease BEFREE Prox1 expression could be useful as a protective factor against recurrence in CD patients. 29947772 2018
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.010 AlteredExpression disease BEFREE However, stable expression of the hepatitis B virus X (HBx) protein inhibited PROX1-mediated TERT expression in vitro. 29987895 2018
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.010 Biomarker disease BEFREE Although Prox-1 labeling was abundant in the area affected by MI, the podoplanin-presenting cells were not consistently Prox-1-positive. 28333941 2017
CUI: C0085207
Disease: Gestational Diabetes
Gestational Diabetes
0.010 GeneticVariation phenotype BEFREE The aim of this study was to examine the association between HHEX (rs5015480) and PROX1 (rs340874) gene polymorphisms and GDM. 27684496 2017
Congenital glucose-galactose malabsorption
0.010 Biomarker disease BEFREE HHEX and PROX1 play significant roles in carbohydrate intolerance and diabetes because these transcription factors may be involved in the regulation of insulin secretion and in glucose and lipid metabolism. 27684496 2017
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 AlteredExpression phenotype BEFREE Liver-specific Prox1 inactivation causes hepatic injury and glucose intolerance in mice. 28129664 2017
CUI: C0346627
Disease: Intestinal Cancer
Intestinal Cancer
0.010 Biomarker disease BEFREE In subgroup analysis, PROX1 was a significant marker of better prognosis in patients aged under 66 (p = 0.007), in those with intestinal cancer (p = 0.025), among men (p = 0.019), and in tumors of less than 5 cm diameter (p = 0.030). 28854215 2017
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.010 GeneticVariation disease BEFREE The rs5128 (APOC3) and rs340874 (PROX1) polymorphisms were found to be significantly associated with susceptibility to MetS (P=0.003 and P=0.033, respectively), with odds ratios (ORs) of 4.39 (95% CI=1.66-11.56) and 2.81 (95% CI=1.09-7.27), respectively. 28919193 2017
CUI: C1401162
Disease: Carbohydrate intolerance
Carbohydrate intolerance
0.010 Biomarker disease BEFREE HHEX and PROX1 play significant roles in carbohydrate intolerance and diabetes because these transcription factors may be involved in the regulation of insulin secretion and in glucose and lipid metabolism. 27684496 2017
CUI: C1512409
Disease: Hepatocarcinogenesis
Hepatocarcinogenesis
0.010 GeneticVariation disease BEFREE Importantly, the results of the present study show an association between gene-specific histone H3K9 deacetylation and a reduced expression of critical cancer-related genes, including prospero homeobox 1 (Prox1), HNF1 homebox A (Hnf1a), and peroxisome proliferator activated receptor alpha (Ppara), which provides a mechanistic link between methapyrilene-induced epigenetic aberrations and liver carcinogenesis. 28013212 2017
CUI: C0002793
Disease: Anaplasia
Anaplasia
0.010 AlteredExpression disease BEFREE We found that Prox1 expression is transiently re-activated in acinar cells undergoing dedifferentiation and acinar-to-ductal metaplastic conversion. 26992918 2016
CUI: C0006118
Disease: Brain Neoplasms
Brain Neoplasms
0.010 Biomarker group BEFREE In addition, PROX1 has been ascribed suppressive as well as oncogenic roles in several human cancers, including brain tumors. 27626492 2016
CUI: C0007115
Disease: Malignant neoplasm of thyroid
Malignant neoplasm of thyroid
0.010 Biomarker disease BEFREE Importantly, restoration of PROX1 activity in thyroid carcinoma cells revealed that PROX1 not only enhanced Wnt/β-catenin signaling but also regulated several genes known to be associated with PTC, including thyroid cancer protein (TC)-1, SERPINA1, and FABP4. 26609053 2016
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.010 AlteredExpression disease BEFREE We discovered that Prox1 upregulation in mature β-cells has no functional consequences; in contrast, Prox1 overexpression in immature β-cells promotes acute fasting hyperglycemia. 26631740 2016
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm
0.010 Biomarker disease BEFREE Importantly, restoration of PROX1 activity in thyroid carcinoma cells revealed that PROX1 not only enhanced Wnt/β-catenin signaling but also regulated several genes known to be associated with PTC, including thyroid cancer protein (TC)-1, SERPINA1, and FABP4. 26609053 2016
CUI: C0334579
Disease: Anaplastic astrocytoma
Anaplastic astrocytoma
0.010 AlteredExpression disease BEFREE In contrast, high expression of PROX1 protein predicted shorter survival in the group of patients with IDH-mutant anaplastic astrocytomas and secondary glioblastomas. 27626492 2016
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.010 Biomarker disease BEFREE In this study, based on different PCa cell lines and knockout mice, we showed that PROX1 could be suppressed by DAB2IP, a novel member of the Ras GTPase-activating protein family and a critical player in control of epithelial-mesenchymal transition (EMT) and PCa metastasis. 27476001 2016
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.010 Biomarker disease BEFREE In this study, based on different PCa cell lines and knockout mice, we showed that PROX1 could be suppressed by DAB2IP, a novel member of the Ras GTPase-activating protein family and a critical player in control of epithelial-mesenchymal transition (EMT) and PCa metastasis. 27476001 2016
CUI: C0022568
Disease: Keratitis
Keratitis
0.010 Biomarker disease BEFREE We determined whether Prox1 siRNA inhibits lymphangiogenesis and hemangiogenesis after acute corneal inflammation. 26348636 2015